Evaluation of an in-house IgM/IgG lateral flow assay for serodiagnosis of human brucellosis

Indian J Med Microbiol. 2023 Mar-Apr:42:55-58. doi: 10.1016/j.ijmmb.2023.01.006. Epub 2023 Feb 3.

Abstract

This study aimed to evaluate the diagnostic efficacy of an in-house lateral flow assay (LFA) for the detection of IgM/IgG anti-Brucella antibodies for rapid serodiagnosis of human brucellosis. Three groups of sera samples including 476 from high-risk individuals, 27 from culture-confirmed patients, and 43 from healthy blood donors were used for evaluation of LFA. In comparison with iELISA, the sensitivity, specificity, and accuracy of LFA were >95%, >99%, and 99% respectively. Considering the very good agreement, accuracy, simplicity, and rapidity, LFAs might be useful as a point of care test for the diagnosis of human brucellosis in resource-limited laboratories.

Keywords: ELISA; Human brucellosis; Lateral flow assay (LFA); RBPT; SAT.

MeSH terms

  • Antibodies, Bacterial
  • Brucellosis* / diagnosis
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Immunoglobulin G
  • Immunoglobulin M
  • Sensitivity and Specificity
  • Serologic Tests

Substances

  • Immunoglobulin M
  • Immunoglobulin G
  • Antibodies, Bacterial